Home / Crime and Justice / Cancer Drug Fraud: UK Pair Face US Extradition
Cancer Drug Fraud: UK Pair Face US Extradition
29 Sep
Summary
- Two individuals face extradition to the US for alleged health program fraud.
- Prosecutors accuse them of providing unapproved cancer drugs for profit.
- An extradition hearing is scheduled for five days at Westminster Magistrates' Court.
Two individuals, Sukhi Ghuman and his ex-wife Kiranjit Ghuman, are currently involved in extradition proceedings to face charges in the United States. Prosecutors allege they defrauded US federal health programs, including Medicare, of millions of dollars between September 2019 and April 2023.
The core accusation involves providing unapproved and cheaper chemotherapy drugs sourced internationally to cancer patients. These were allegedly administered at oncology clinics controlled by the accused in California and Arizona, while presenting them as approved treatments to insurance providers. Some of the supplied medicine was reportedly out of date.
Sukhi Ghuman has previously denied all allegations, stating his intention was to help patients unable to afford necessary cancer treatments and disputing claims of personal profit. A warrant for their arrest was issued in October 2023 by the Southern District of California. The extradition hearing at Westminster Magistrates' Court is scheduled to last five days.
